Silexion Therapeutics Corp (NASDAQ:SLXN) price closed higher on Tuesday, February 25, and jumping 64.00% above its previous close.
A look at the daily price movement shows that the last close reads $0.75. Taking into account the 52-week price action we note that the stock hit a 52-week high of $122.02 and 52-week low of $0.57. The stock added 85.38% on its value in the past month.
Silexion Therapeutics Corp, which has a market valuation of $10.35 million, is expected to release its quarterly earnings report in March.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.
The overview shows that SLXN’s price is at present -10.39% off the SMA20 and -29.65% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 48.07, with weekly volatility standing at 26.63%. The indicator jumps to 25.92% when calculated based on the past 30 days. Silexion Therapeutics Corp (NASDAQ:SLXN)’s beta value is holding at 0.12, while the average true range (ATR) indicator is currently reading 0.33.
An analysis of the Silexion Therapeutics Corp (NASDAQ:SLXN) stock in terms of its daily trading volume indicates that the 3-month average is 11.35 million.
Current records show that the company has 8.41M in outstanding shares. The insiders’ percentage holdings are 19.06% of outstanding shares while the percentage share held by institutions stands at 7.03%. But the -38.81% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
